NDC 71332-005

REZLIDHIA

Olutasidenib

REZLIDHIA is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Rigel Pharmaceuticals, Inc.. The primary component is Olutasidenib.

• Product ID: 71332-005_c9a5b2db-b491-4a67-9cfc-c6228f0e3843
• NDC: 71332-005
• Product Type: Human Prescription Drug
• Proprietary Name: REZLIDHIA
• Generic Name: Olutasidenib
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2022-12-01
• Marketing Category: NDA /
• Application Number: NDA215814
• Labeler Name: Rigel Pharmaceuticals, Inc.
• Substance Name: OLUTASIDENIB
• Active Ingredient Strength: 150 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 71332-005-01

30 CAPSULE in 1 BOTTLE (71332-005-01)

• Marketing Start Date: 2022-12-01
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details